These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 14550701)
1. Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. Chan D; Janssen JC; Whitwell JL; Watt HC; Jenkins R; Frost C; Rossor MN; Fox NC Lancet; 2003 Oct; 362(9390):1121-2. PubMed ID: 14550701 [TBL] [Abstract][Full Text] [Related]
2. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Ridha BH; Barnes J; Bartlett JW; Godbolt A; Pepple T; Rossor MN; Fox NC Lancet Neurol; 2006 Oct; 5(10):828-34. PubMed ID: 16987729 [TBL] [Abstract][Full Text] [Related]
3. Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry. Ho AJ; Hua X; Lee S; Leow AD; Yanovsky I; Gutman B; Dinov ID; Leporé N; Stein JL; Toga AW; Jack CR; Bernstein MA; Reiman EM; Harvey DJ; Kornak J; Schuff N; Alexander GE; Weiner MW; Thompson PM; Hum Brain Mapp; 2010 Apr; 31(4):499-514. PubMed ID: 19780044 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets. Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL; Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169 [TBL] [Abstract][Full Text] [Related]
5. Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: correlations with disease severity. Murphy DG; DeCarli CD; Daly E; Gillette JA; McIntosh AR; Haxby JV; Teichberg D; Schapiro MB; Rapoport SI; Horwitz B Biol Psychiatry; 1993 Nov; 34(9):612-21. PubMed ID: 8292690 [TBL] [Abstract][Full Text] [Related]
6. [Contribution of morphological imaging in the diagnosis of dementia. I--Alzheimer disease]. Scheltens P; Leys D; Barkhof F; Vermersch P; Steinling M; Weinstein HC; Pruvo JP; Petit H Rev Med Interne; 1994 May; 15(6):415-22. PubMed ID: 8059176 [TBL] [Abstract][Full Text] [Related]
7. [Clinical presentation of Moroccan cases with Alzheimer's disease]. El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896 [TBL] [Abstract][Full Text] [Related]
8. Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease. Younes L; Albert M; Miller MI; Neuroimage Clin; 2014; 5():178-87. PubMed ID: 25101236 [TBL] [Abstract][Full Text] [Related]
9. Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease? Korf ES; Scheltens P; Barkhof F; de Leeuw FE Dement Geriatr Cogn Disord; 2005; 20(6):331-7. PubMed ID: 16179827 [TBL] [Abstract][Full Text] [Related]
10. Topographical patterns of lobar atrophy in frontotemporal dementia and Alzheimer's disease. Bocti C; Rockel C; Roy P; Gao F; Black SE Dement Geriatr Cogn Disord; 2006; 21(5-6):364-72. PubMed ID: 16534206 [TBL] [Abstract][Full Text] [Related]
11. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy. Staekenborg SS; Koedam EL; Henneman WJ; Stokman P; Barkhof F; Scheltens P; van der Flier WM Stroke; 2009 Apr; 40(4):1269-74. PubMed ID: 19228848 [TBL] [Abstract][Full Text] [Related]
12. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Fox NC; Crum WR; Scahill RI; Stevens JM; Janssen JC; Rossor MN Lancet; 2001 Jul; 358(9277):201-5. PubMed ID: 11476837 [TBL] [Abstract][Full Text] [Related]
13. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease. Benedictus MR; Leeuwis AE; Binnewijzend MA; Kuijer JP; Scheltens P; Barkhof F; van der Flier WM; Prins ND Eur Radiol; 2017 Mar; 27(3):1169-1175. PubMed ID: 27334014 [TBL] [Abstract][Full Text] [Related]
14. Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease. Hamelin L; Lagarde J; Dorothée G; Potier MC; Corlier F; Kuhnast B; Caillé F; Dubois B; Fillon L; Chupin M; Bottlaender M; Sarazin M Brain; 2018 Jun; 141(6):1855-1870. PubMed ID: 29608645 [TBL] [Abstract][Full Text] [Related]
15. Assessing the onset of structural change in familial Alzheimer's disease. Schott JM; Fox NC; Frost C; Scahill RI; Janssen JC; Chan D; Jenkins R; Rossor MN Ann Neurol; 2003 Feb; 53(2):181-8. PubMed ID: 12557284 [TBL] [Abstract][Full Text] [Related]
16. Imaging cerebral atrophy: normal ageing to Alzheimer's disease. Fox NC; Schott JM Lancet; 2004 Jan; 363(9406):392-4. PubMed ID: 15074306 [TBL] [Abstract][Full Text] [Related]
17. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Burton EJ; Barber R; Mukaetova-Ladinska EB; Robson J; Perry RH; Jaros E; Kalaria RN; O'Brien JT Brain; 2009 Jan; 132(Pt 1):195-203. PubMed ID: 19022858 [TBL] [Abstract][Full Text] [Related]
18. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. Wahlund LO; Julin P; Johansson SE; Scheltens P J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):630-5. PubMed ID: 11032615 [TBL] [Abstract][Full Text] [Related]
19. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Davatzikos C; Xu F; An Y; Fan Y; Resnick SM Brain; 2009 Aug; 132(Pt 8):2026-35. PubMed ID: 19416949 [TBL] [Abstract][Full Text] [Related]
20. Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression. Ridha BH; Anderson VM; Barnes J; Boyes RG; Price SL; Rossor MN; Whitwell JL; Jenkins L; Black RS; Grundman M; Fox NC J Neurol; 2008 Apr; 255(4):567-74. PubMed ID: 18274807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]